Target Name: ZNF488
NCBI ID: G118738
Review Report on ZNF488 Target / Biomarker Content of Review Report on ZNF488 Target / Biomarker
ZNF488
Other Name(s): ZNF488 variant 2 | Zinc finger protein 488 | ZN488_HUMAN | Zinc finger protein 488, transcript variant 2 | zinc finger protein 488

ZNF488: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Diseases

The ZNF488 gene is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for the treatment of inflammatory diseases. The ZNF488 gene is a member of the Zinc finger gene family, which is known for its role in regulating gene expression and has been implicated in the development and progression of a wide range of diseases, including inflammatory diseases.

The ZNF488 gene has been shown to play a key role in the regulation of immune and inflammatory responses, as well as cell survival and proliferation. It is expressed in a variety of tissues and cells, including immune cells, epithelial cells, and neural cells.

Potential Drug Target

The ZNF488 gene is a potential drug target for the treatment of inflammatory diseases because of its involvement in the regulation of inflammation and immune responses. Many inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, and asthma, are characterized by chronic inflammation and persistent immune activation. The ZNF488 gene has been shown to play a key role in the regulation of these processes, and may be a useful target for the development of new treatments for these diseases.

One way to target the ZNF488 gene is through the use of small molecules, such as drugs that can modulate its expression or activity. These small molecules can be administered to the body to reduce inflammation and improve immune function. Currently, there are several ongoing clinical trials using small molecules to target the ZNF488 gene in the treatment of inflammatory diseases.

Biomarker

In addition to its potential as a drug target, the ZNF488 gene is also a potential biomarker for the diagnosis and monitoring of inflammatory diseases. The ZNF488 gene is expressed in a variety of tissues and cells and has been shown to be involved in the regulation of inflammation and immune responses. By measuring the expression and activity of the ZNF488 gene, researchers may be able to diagnose and monitor the severity of inflammatory diseases and the effectiveness of new treatments.

The ZNF488 gene has been shown to be involved in the regulation of cytokine production and immune cell function. It has been shown to play a role in the regulation of T cell development and function, as well as the regulation of inflammation. These functions make the ZNF488 gene an attractive candidate for use as a biomarker for the diagnosis and monitoring of inflammatory diseases.

Conclusion

The ZNF488 gene is a non-coding RNA molecule that has been shown to play a key role in the regulation of immune and inflammatory responses. Its expression and activity have been implicated in the development and progression of a wide range of diseases, including inflammatory diseases. The ZNF488 gene is a potential drug target and biomarker for the treatment of inflammatory diseases, and further research is needed to fully understand its role in these processes.

Protein Name: Zinc Finger Protein 488

Functions: Transcriptional repressor. Plays a role in oligodendrocyte differentiation, together with OLIG2. Mediates Notch signaling-activated formation of oligodendrocyte precursors. Promotes differentiation of adult neural stem progenitor cells (NSPCs) into mature oligodendrocytes and contributes to remyelination following nerve injury

The "ZNF488 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF488 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT